ASMB 1Q19 results—3/31/19 cash=$193.5M; 1Q19 burn=$24.6M: https://www.globenewswire.com/news-release/2019/05/09/1821361/0/en/Assembly-Biosciences-Reports-First-Quarter-2019-Financial-Results-and-Recent-Highlights.html ASMB is a competitor of ENTA in HBV (#msg-148672065).